Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism GDF15 agonists(Growth/differentiation factor 15 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Juvenescence Ltd.Startup |
Active Organization Juvenescence Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Atrophy | Preclinical | IM | Juvenescence Ltd.Startup | 01 Apr 2024 |
Neoplasms | Preclinical | IM | Juvenescence Ltd.Startup | 01 Apr 2024 |